Literature DB >> 20865363

A functional analysis of G23A polymorphism and the alternative splicing in the expression of the XPA gene.

Dorota Butkiewicz1, Małgorzata Krześniak, Rasa Vaitiekunaite, Bozena Sikora, Elise D Bowman, Curtis C Harris, Marek Rusin.   

Abstract

The XPA gene has a commonly occurring polymorphism (G23A) associated with cancer risk. This study assessed the functional significance of this polymorphism, which is localised near the translation start codon. Lymphoblastoid cell lines with alternative homozygous genotypes showed no significant differences in their XPA levels. The luciferase reporter assay detected no functional difference between the two sequences. Unexpectedly, we found that the alternatively spliced form of XPA mRNA lacked a part of exon 1. Only the reading frame downstream of codon Met59 was preserved. The alternative mRNA is expressed in various human tissues. The analysis of the 5'cDNA ends showed similar transcription start sites for the two forms. The in vitro expression of the alternative XPA labelled with the red fluorescent protein (mRFP) showed a lack of preferential nuclear accumulation of the XPA isoform. The biological role of the alternative XPA mRNA form remains to be elucidated.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20865363      PMCID: PMC6275895          DOI: 10.2478/s11658-010-0032-2

Source DB:  PubMed          Journal:  Cell Mol Biol Lett        ISSN: 1425-8153            Impact factor:   5.787


  41 in total

Review 1.  Polymorphisms in DNA repair genes and associations with cancer risk.

Authors:  Ellen L Goode; Cornelia M Ulrich; John D Potter
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2002-12       Impact factor: 4.254

Review 2.  Variation in DNA repair is a factor in cancer susceptibility: a paradigm for the promises and perils of individual and population risk estimation?

Authors:  H W Mohrenweiser; I M Jones
Journal:  Mutat Res       Date:  1998-05-25       Impact factor: 2.433

Review 3.  Interpreting cDNA sequences: some insights from studies on translation.

Authors:  M Kozak
Journal:  Mamm Genome       Date:  1996-08       Impact factor: 2.957

4.  A novel XPA gene mutation and its functional analysis in a Japanese patient with xeroderma pigmentosum group A.

Authors:  Miki Tanioka; Arief Budiyant; Takahiro Ueda; Tohru Nagano; Masamitsu Ichihashi; Yoshiki Miyachi; Chikako Nishigori
Journal:  J Invest Dermatol       Date:  2005-08       Impact factor: 8.551

5.  Kozak sequence polymorphism of the glycoprotein (GP) Ibalpha gene is a major determinant of the plasma membrane levels of the platelet GP Ib-IX-V complex.

Authors:  V Afshar-Kharghan; C Q Li; M Khoshnevis-Asl; J A López
Journal:  Blood       Date:  1999-07-01       Impact factor: 22.113

6.  Interindividual variation in nucleotide excision repair genes and risk of endometrial cancer.

Authors:  Jocelyn M Weiss; Noel S Weiss; Cornelia M Ulrich; Jennifer A Doherty; Lynda F Voigt; Chu Chen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-11       Impact factor: 4.254

7.  XPA polymorphism associated with reduced lung cancer risk and a modulating effect on nucleotide excision repair capacity.

Authors:  Xifeng Wu; Hua Zhao; Qingyi Wei; Christopher I Amos; Kerang Zhang; Zhaozheng Guo; Yawei Qiao; Waun K Hong; Margaret R Spitz
Journal:  Carcinogenesis       Date:  2003-03       Impact factor: 4.944

Review 8.  Cancer in xeroderma pigmentosum and related disorders of DNA repair.

Authors:  James E Cleaver
Journal:  Nat Rev Cancer       Date:  2005-07       Impact factor: 60.716

9.  XPA A23G polymorphism is associated with the elevated response to platinum-based chemotherapy in advanced non-small cell lung cancer.

Authors:  Jifeng Feng; Xinchen Sun; Ning Sun; Shukui Qin; Fan Li; Hongyan Cheng; Baoan Chen; Yuandong Cao; Jun Ma; Lu Cheng; Zuhong Lu; Jiazhong Ji; Yingfeng Zhou
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2009-05       Impact factor: 3.848

Review 10.  Genetic polymorphisms in the nucleotide excision repair pathway and lung cancer risk: a meta-analysis.

Authors:  Chikako Kiyohara; Kouichi Yoshimasu
Journal:  Int J Med Sci       Date:  2007-02-01       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.